Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Added)

Clinical trial NCT00634309 · COMPLETED

Trial details

NCT number: NCT00634309
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Congestive Heart Failure

Start date: 1999-06-01
Primary completion: 2003-05-01
Enrollment: 597

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.